{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T18:41:20Z","timestamp":1698777680703},"reference-count":43,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2007,6,12]],"date-time":"2007-06-12T00:00:00Z","timestamp":1181606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2007,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The conventional direct referral to colposcopy of persistent borderline or mildly dyskaryotic (BMD) smears in cervical cancer screening leads to considerable unnecessary referrals and associated anxiety and costs. This may be improved by including testing for oncogenic human papillomavirus (HPV) in the triage. We assessed costs and side effects (referrals, treatments and time in follow\u2010up) for 3 possible HPV triage strategies (immediate HPV testing, a 6\u2010month delay in HPV testing, a 2\u2010stage combination of both) and compared them with the conventional strategy. The assessments are based on recent Dutch data from various national databases and trials. We estimated that the referral rate could be reduced by 49, 58 and 58% with immediate, delayed and 2\u2010stage HPV testing, respectively. As a consequence, the average length of follow\u2010up, as well as average costs, also decrease. Therefore, we advocate including HPV testing before referring to colposcopy. Among the 3 HPV strategies, analysis of additional aspects favors implementation of immediate HPV testing. \u00a9 2007 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ijc.22838","type":"journal-article","created":{"date-parts":[[2007,6,12]],"date-time":"2007-06-12T19:17:37Z","timestamp":1181675857000},"page":"1529-1535","source":"Crossref","is-referenced-by-count":9,"title":["Human papillomavirus triage of women with persistent borderline or mildly dyskaryotic smears: Comparison of costs and side effects of three alternative strategies"],"prefix":"10.1002","volume":"121","author":[{"given":"Matejka","family":"Rebolj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aagje G.","family":"Bais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjolein","family":"van Ballegooijen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Boer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem\u2010Jan","family":"Meerding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theo J.M.","family":"Helmerhorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Dik F.","family":"Habbema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,6,12]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22167"},{"issue":"4","key":"e_1_2_6_3_2","first-page":"S1","article-title":"European guidelines for quality assurance in cervical cancer screening. Europe against cancer programme","volume":"29","author":"Coleman D","year":"1993","journal-title":"Eur J Cancer A"},{"key":"e_1_2_6_4_2","volume-title":"Nijmegen","author":"Dutch Association of Pathologists","year":"1997"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(00)00310-5"},{"key":"e_1_2_6_6_2","volume-title":"Dutch Network and National Database for Pathology (PALGA): results of retrieval action on cervical cytology until 31\u201003\u20102004","author":"Prismant","year":"2004"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.53.6.439"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20958"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2000.5929"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10257"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1995.42"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0412.2003.00155.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.322.7291.893"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.981"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh037"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.4.293"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06809-X"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh063"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj035"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.332.7535.237"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2003.011841"},{"key":"e_1_2_6_23_2","unstructured":"Dutch Association of Obstetricians and Gynaecologists. Guidelines for treatment of cervical intraepithelial neoplasia Version 1.1. Available at:http:\/\/www.nvog.nl(in Dutch) 2004."},{"key":"e_1_2_6_24_2","volume-title":"The effects and costs of the cervical cancer screening programme in the Netherlands after the changes (In Dutch)","author":"Ballegooijen MV","year":"2006"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21513"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004347-199304000-00018"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000114983.11562.08"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(95)00243-C"},{"key":"e_1_2_6_29_2","volume-title":"LMR data on hospital admissions 1975\u20132000","author":"Prismant","year":"2003"},{"key":"e_1_2_6_30_2","volume-title":"Triage of women with atypical or low\u2010grade cytological abnormalities of the cervix by HPV testing: systematic review and meta\u2010analysis (Preliminary report). European Network for Cervical Cancer Screening","author":"Arbyn M","year":"2001"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2006.01.091"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20076"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601157"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1991.350"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199203000-00004"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(01)01526-5"},{"key":"e_1_2_6_37_2","first-page":"15","article-title":"Characteristics of effective clinical guidelines for general practice","volume":"53","author":"Burgers JS","year":"2003","journal-title":"Br J Gen Pract"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602411"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2004.00279.x"},{"key":"e_1_2_6_40_2","first-page":"849","article-title":"Management of the low\u2010grade abnormal Pap smear: what are women's preferences?","volume":"51","author":"Melnikow J","year":"2002","journal-title":"J Fam Pract"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1348\/1359107042304560"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-0528.2003.00007.x"},{"key":"e_1_2_6_43_2","unstructured":"BulkmansNW BerkhofJ BulkS BleekerMCG van KemenadeFJ RozendaalL SnijdersPJ MeijerCJ.Differences in clearance rates of 14 hr\u2010HPV types in large\u2010scale population\u2010based cervical screening. In: Monsonego J ed. Eurogin Conference Proceedings Paris Palais des congres April 23\u201326 2006.71."},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1997.20"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.22838","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.22838","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T20:10:29Z","timestamp":1696795829000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.22838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,12]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["10.1002\/ijc.22838"],"URL":"https:\/\/doi.org\/10.1002\/ijc.22838","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,12]]}}}